Patents
Sitemap › C07 - Organic chemistry › C07F - Acyclic, carbocyclic, or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium › C07F 9 - Compounds containing elements of the 5th group of the periodic system
Patents for C07F 9 - Compounds containing elements of the 5th group of the periodic system (55,377)
08/2010
08/03/2010US7767662 17-amino analogs of geldanamycin, used for treating and modulating disorders associated with hyperproliferation, such as cancer; antiproliferative and anticarcinogenic agents
07/2010
07/29/2010WO2010084360A1 Ligands
07/29/2010WO2010083989A1 Light and heat stabilized polyamides and methods for the production thereof
07/29/2010WO2010083570A1 Novel metabolic disease therapy
07/29/2010WO2010054383A3 Electrically conducting microporous frameworks
07/29/2010WO2010006238A3 Stimulus-responsive apta-chelamers
07/29/2010US20100190985 Heterodiamondoids
07/29/2010US20100190901 Alkylphosphonous Acids, Salts and Esters, Methods for the Production Thereof, and Use of the Same
07/29/2010US20100190753 Methods and Compositions for Treating Amyloid-Related Diseases
07/29/2010US20100189795 Calcium sequestration compositions and methods of treating skin pigmentation disorders and conditions
07/29/2010US20100187520 Light emitting device material and light emitting device
07/29/2010US20100187505 Benzanthracene derivatives for organic electroluminescent devices
07/29/2010US20100186961 Alpha amino acid phosphonic acid compounds, method of preparation of use thereof
07/28/2010EP2209476A1 Use of toll-like receptor-9 agonists, toll-like receptor-4 antagonists, and/or nuclear oligomerization domain-2 agonists for the treatment or prevention of toll-like receptor-4-associated disorders
07/28/2010CN101790509A Process for preparing estrogen-antagonistic 11 ss-fluoro-17alpha-alkylestra-1,3,5(10)-triene-3,17-diols having a 7alpha-(xi-alkylamino-omega-perfluoroalkyl)alkyl side chain and a-alkyl(amino)-omega-perfluoro(alkyl)alkanes and processes for their preparation
07/28/2010CN101787049A Novel crystal form of cocarboxylase tetrahydrate and preparation method thereof
07/28/2010CN101787048A Preparation method of cocarboxylase tetrahydrate
07/28/2010CN101787047A Fluorocarbon chain or/and hydrocarbon chain containing phosphatidylcholine blocking agent with hydroxyl or amino at tail end and polyurethane material for blocking same
07/28/2010CN101786938A Method for recycling chloromethane during production of glyphosate by using glycine method
07/28/2010CN101148434B Method for synthesizing pentadecane triphenyl phosphonium salt
07/27/2010US7763739 bidentante optionally N-containing P-ligands embracing a two-ring-system; for transition metal complexes to be used as catalysts
07/27/2010US7763649 Treating cardiac arrhythmia and/or cancerous and pre-cancerous cells by administering specific synthetic carotenoid analogs or derivatives either alone or in combination with another carotenoid analog or derivative, or co-antioxidant formulation
07/27/2010US7763563 Niobium compounds and hydrates thereof, formulations containing the same, and methods of providing specifications therefor
07/27/2010CA2448319C Cytotoxins, prodrugs, linkers and stabilizers useful therefor
07/22/2010WO2009132241A3 Proton conducting materials
07/22/2010US20100184974 Protease Inhibitors
07/22/2010US20100184718 Compositions and Methods for Double-Targeting Virus Infections and Targeting Cancer Cells
07/22/2010US20100183705 Phospholipid-analogous compounds
07/22/2010US20100183600 RAF Inhibitors and Their Uses
07/22/2010US20100183517 Peptidomimetic Inhibitors Of PSMA, Compounds Comprising Them, And Methods Of Use
07/21/2010EP2207783A1 Method for hydroformylation
07/21/2010EP2207421A1 Haloalkylsubstituted aryloxyalkylimidazolines for use as pesticides
07/21/2010EP1751128B1 Chromene-derivatives with anti-tubulin and vascular targeting activity
07/21/2010EP1697388B1 Method for producing phosphonium salts
07/21/2010CN1918126B Ionic UV-A sunscreens and compositions containing them
07/21/2010CN101781335A New tenofovir disoproxil fumarate crystal and preparation method thereof
07/21/2010CN101781334A Salt compound of tenofovir disoproxil fumarate and preparation method and medicinal application thereof
07/21/2010CN101781333A Adefovir dipivoxil crystal form and preparation method thereof
07/21/2010CN101781332A Method for preparing glyphosate by activated carbon catalysis and air oxidation of PMIDA (N-(phosphonomethyl)iminodiacetic acid)
07/21/2010CN101781331A Method for extracting glyphosate from glyphosate dilute solution
07/21/2010CN101781330A Propofol, phosphate and amino acid double salt and preparation method and application thereof
07/21/2010CN101781329A Propofol derivative for therapy
07/21/2010CN101781238A Method for synthesizing inorganic solvent of thioether, thiocyanate and sulfuric phosphate
07/21/2010CN101781007A Method for extracting panaplate from mother solution or waste water of dipterex
07/21/2010CN101255174B Novel process for synthesis of acephate
07/20/2010US7759522 Process for purification of phosphate esters
07/20/2010US7759506 Solubilizing; diffusion oxygen into tissue of mammals, humans; respiratory system disorders; antiischemic agents; antidiabetic agents; Alzheimer's disease; aftertreatment surgery
07/20/2010US7759491 anti-tumor activity, protein kinase inhibitory activity
07/20/2010US7759392 4-nitroxybutyric acid ester derivatives of drugs such as acetaminophen, having an improved therapeutic index (efficacy/toxicity ratio) or a lower risk/benefit ratio, usedfor treating oxidative stress and endothelian dysfunctions, inflammation and pain
07/20/2010US7759370 Immunosuppressants for autoimmune diseases such as multiple sclerosis, transplant rejection; sphingosine-1-phosphate (S1P) receptor agonists; (S)-2-Amino-2-(5-(4-(2-(pentyloxy)ethoxy)-3-(trifluoromethyl)phenyl)-1,3,4-thiadiazol-2-yl)propyl dihydrogen phosphate for example
07/20/2010US7759326 Modulate sphingosine-1-phosphate (S1P) receptors with fewer side effects; for example, 2-amino-5-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]-2-methylpentylphosphonic acid monoester; prophylactic or therapeutic agents against rejection of organ transplants, skin grafts, rheumatoid arthritis, lupus
07/20/2010CA2473954C Separation of acids from chemical reaction mixtures by means of ionic liquids
07/20/2010CA2322487C Novel prodrugs for phosphorus-containing compounds
07/20/2010CA2268740C High density immobilization of nucleic acids
07/15/2010WO2010080425A1 Method of making hydroxymethylphosphonate, polyurethane foam-forming compositions polyurethane foam and articles made thereform
07/15/2010WO2010080396A2 Composition and method to provide stain release and stain repellency properties to substrates
07/15/2010WO2010079051A1 Silyl and heteroatom substituted compounds selected from carbazoles, dibenzofurans, dibenzothiophenes and dibenzo phospholes and the application thereof in organic electronics
07/15/2010US20100179342 Process for making dihydrocarbyl hydrocarbonphosphonates
07/15/2010US20100179324 Anti-tumor agent comprising sulphostin or sulphostin-related compound as the active ingredient
07/15/2010US20100179311 Reactions of group 16 elements
07/15/2010US20100179300 Product containing epichlorohydrin, its preparation and its use in various applications
07/15/2010US20100179127 Pyrimidine derivatives
07/15/2010US20100179107 N-acyl-phosphatidyl-ethanolamines and/or mixtures of n-acyl-ethanolamines with phosphatidic acids or lysophosphatidic acids
07/15/2010US20100179106 Mitochondrial compositions and uses thereof
07/15/2010US20100176031 Porous solids, selective separations, removal of sulfur compounds, adsorption
07/15/2010DE202004021723U1 Medizinische Verwendung von Hemmern von Glutaminyl- und Glutamatcyclasen Medical use of inhibitors of glutaminyl and Glutamatcyclasen
07/14/2010EP2206749A1 Phthalocyanine compound
07/14/2010EP2206718A1 Organophosphorus compound having phosphate-phosphonate bond, and flame-retardant polyester fiber and flame-retardant polyurethane resin composition each containing the same
07/14/2010EP2206717A1 A process for the preparation of alkyl- and aryl-diphosphonic acids and salts thereof
07/14/2010EP2206496A1 Medical use of inhibitors of glutaminyl and glutamate cyclases
07/14/2010EP2205614A1 Process for continuously preparing an organophosphorus compound and use thereof
07/14/2010EP2205613A2 Biocompatible suspension stabilizer for dispersing inorganic nanoparticles into aqueous solution
07/14/2010EP2061829B1 Liquid polymeric phosphites and phosphonites as stabilizers
07/14/2010EP1818335B1 Phosphorylcholine group-containing compound and method for producing same
07/14/2010CN101778855A Tenofovir disoproxil hemi-fumaric acid co-crystal
07/14/2010CN101778853A Method for preparing a solution of a rare-earth organophosphate in an organic solvent
07/14/2010CN101775135A Carboxyethyl phenyl phosphinic acid piperazine polymer and preparation method thereof
07/14/2010CN101775041A 2-acyl 1,3-indane dione silver compound with stable organic phosphine, preparation method and application thereof
07/14/2010CN101775037A Organic antimony compound and preparation method and application thereof
07/14/2010CN101775036A Method for preparing tetraphenylphosphonium bromide by non-solvent method
07/14/2010CN101775035A Synthesis of class of amino acid type amphoteric water-soluble chiral phosphine ligand and application thereof in asymmetric catalytic hydrogenation
07/14/2010CN101775034A Method for synthesizing propyl phosphonic acid methyl ester
07/14/2010CN101775033A Preparation method of phosphite ester by using dividing wall tower reaction rectification technique
07/14/2010CN101775032A Niclosamide phosphate ester and pharmaceutically acceptable salt and application thereof
07/14/2010CN101775031A Method for preparing TCPP (Tris(Chloroisopropyl)Phosphate) flame retardant
07/14/2010CN101775030A Preparing sterile articles from polymers containing a stabiliser based on a poly(oxyalkylene)
07/14/2010CN101775010A Carbazole-terminated heterofluorene main body material and preparation and application method
07/14/2010CN101619077B Method for preparing N-Phosphonomethyl iminodiacetic acid through hydrolyzing iminodiacetonitrile
07/14/2010CN101052615B Metal compound, thin film-forming material, and method for producing thin film
07/13/2010US7754907 Allosterically catalyzed signal amplification in chemical and biological sensing
07/13/2010US7754772 (2R)-2,3-bis(nitrooxy)propyl(2S)-2(6-methoxy(2-naphthyl)propanoate, used for treating inflammation, pain and fever; gastrointestinal disorders; wound healing agents; preventing gastrointestinal, renal and/or respiratory toxicities; side effect reduction
07/13/2010US7754723 Therapeutic agents useful for treating pain
07/13/2010US7754703 potent, and selective agonists for G protein-coupled receptors (S1P1); to treat autoimmune diseases, such as, uveitis, type I diabetes, rheumatoid arthritis, inflammatory bowel diseases, multiple sclerosis, cancer, neurodegenerative diseases; (1-amino-3-(4-octylphenyl cyclopentyl)methanol
07/13/2010US7754662 reacting an organophosphate such as ZDDP (zinc dialkyldithiophosphate) with an organofluorine compound or polymer such as polytetrafluoroethylene; levels of catalytic converter poisons phosphorus and sulfur approach zero; environmentally friendly
07/13/2010US7754462 increases in the yield and selectivity; can be used as co-solvents to improve the solubility of educts and products
07/13/2010US7754200 Phosphate transport inhibitors
07/08/2010WO2010078449A2 Compounds and methods for inhibiting nhe-mediated antiport in the treatment of disorders associated with fluid retention or salt overload and gastrointestinal tract disorders
07/08/2010WO2010076995A2 Novel phosphonate based compound and flame retardant styrenic resin composition including the same
07/08/2010WO2010076968A2 Vanadium phthalocyanine compounds and near-infrared absorption filter using the same
07/08/2010WO2010076433A1 Novel fluorescent boron-substituted dipyrromethenes and use thereof for diagnosis
1 ... 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 ... 554